Publications While At Healthpartners
Consensus recommendations for the use of automated insulin delivery technologies in clinical practice
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: the head-to-head randomized controlled InRange trial
Diabetes, Obesity & Metabolism.
InRange: comparison of the second-generation basal insulin analogues glargine 300 U/mL and degludec 100 U/mL in persons with type 1 diabetes using continuous glucose monitoring-study design
Consensus report of the coalition for clinical research-self-monitoring of blood glucose
Journal of Diabetes Science and Technology.
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement [review]
The lancet. Diabetes & endocrinology.
Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time-in-Range [review]
International consensus on use of continuous glucose monitoring [review]
Map of science